Drug intelligence / Profile preview

Radicle Rest

Development stage: Preclinical
Lead developer: Radicle Science
Modality: Small Molecules
Administration: Oral

Overview

Radicle Rest is a cannabinoid-based wellness product line developed and evaluated by Radicle Science. The formulations typically consist of plant-derived cannabinoids, such as cannabidiol (CBD) and cannabinol (CBN), and are specifically designed to address sleep disturbances and improve overall sleep quality. These products are the subject of large-scale, decentralized, randomized, double-blind, placebo-controlled "Real World Evidence" (RWE) clinical trials. These studies aim to provide rigorous clinical validation for non-prescription health and wellness products, assessing their impact on sleep, anxiety, and related health outcomes in a diverse, real-world population.

Brand names: Radicle Rest
Other names: Radicle Rest VGIRadicle Rest 24Radicle Rest 2

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on Radicle Rest.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Radicle Rest.

Explore the full profile